Literature DB >> 3302101

Immunological differences between the envelope glycoproteins of two strains of human respiratory syncytial virus.

E E Walsh, M W Brandriss, J J Schlesinger.   

Abstract

The envelope glycoproteins of two distinct strains of respiratory syncytial virus (RSV) (Long and 18537 strains) were purified by affinity chromatography and characterized by immunological methods. The fusion (F) proteins from the two strains were similar in molecular weight by gel electrophoresis and were very closely related immunologically. Rabbit antisera to either F protein reacted with near equivalent titres with the heterologous F protein by Western blot, enzyme-linked immunoassay (EIA), neutralization and fusion inhibition assays. In contrast to the similarity of the F proteins, the attachment proteins (G) differed significantly. The 18537 G protein had a molecular weight of 78K compared to 84K for the Long G protein. Rabbit antisera to the G proteins clearly reacted preferentially with the homologous protein, although some cross-reactivity was noted by Western blot and EIA. Anti-G serum neutralized the homologous strain of RSV in the presence or absence of complement to much higher titre than the heterologous virus strain. The implications for vaccine development are discussed.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3302101     DOI: 10.1099/0022-1317-68-8-2169

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  10 in total

1.  Antibody response to the central unglycosylated region of the respiratory syncytial virus attachment protein in mice.

Authors:  Yoshihiko Murata; Seana C Catherman
Journal:  Vaccine       Date:  2012-06-19       Impact factor: 3.641

2.  Induction of a neutralizing immune response to human respiratory syncytial virus with anti-idiotypic antibodies.

Authors:  C Palomo; J P Albar; B García-Barreno; J A Melero
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

Review 3.  Respiratory syncytial virus genetic and antigenic diversity.

Authors:  W M Sullender
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

4.  Identification of amino acids recognized by syncytium-inhibiting and neutralizing monoclonal antibodies to the human parainfluenza type 3 virus fusion protein.

Authors:  K V Coelingh; E L Tierney
Journal:  J Virol       Date:  1989-09       Impact factor: 5.103

5.  Neutralization epitopes of the F glycoprotein of respiratory syncytial virus: effect of mutation upon fusion function.

Authors:  J A Beeler; K van Wyke Coelingh
Journal:  J Virol       Date:  1989-07       Impact factor: 5.103

Review 6.  Respiratory syncytial virus infection in adults.

Authors:  A R Falsey; E E Walsh
Journal:  Clin Microbiol Rev       Date:  2000-07       Impact factor: 26.132

7.  RNA fingerprinting of respiratory syncytial virus using ribonuclease protection. Application to molecular epidemiology.

Authors:  G A Storch; C S Park; D E Dohner
Journal:  J Clin Invest       Date:  1989-06       Impact factor: 14.808

8.  Genetic vaccine for respiratory syncytial virus provides protection without disease potentiation.

Authors:  Teresa R Johnson; David Rangel; Barney S Graham; Douglas E Brough; Jason G Gall
Journal:  Mol Ther       Date:  2013-06-10       Impact factor: 11.454

9.  Structure basis of neutralization by a novel site II/IV antibody against respiratory syncytial virus fusion protein.

Authors:  Qingqing Xie; Zhao Wang; Fengyun Ni; Xiaorui Chen; Jianpeng Ma; Nita Patel; Hanxin Lu; Ye Liu; Jing-Hui Tian; David Flyer; Michael J Massare; Larry Ellingsworth; Gregory Glenn; Gale Smith; Qinghua Wang
Journal:  PLoS One       Date:  2019-02-07       Impact factor: 3.240

Review 10.  Intervention Strategies for Seasonal and Emerging Respiratory Viruses with Drugs and Vaccines Targeting Viral Surface Glycoproteins.

Authors:  Ralph A Tripp; John Stambas
Journal:  Viruses       Date:  2021-04-06       Impact factor: 5.048

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.